Article Details
Retrieved on: 2021-03-01 19:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Daratumumab was the first anti-CD38 monoclonal antibody approved for the treatment of patients with cancer. He also led the research that led the FDA ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here